Quantifying Coronary Inflammation, Redefining Risk

Sponsored by Caristo Diagnostics

Paid Advertisement

Clinical guidelines support targeting inflammation to improve cardiovascular outcomes, while recent trial data sharpen the question of how coronary inflammation should be measured and acted on in practice. This Caristo Learning Studio session will examine what the data reveal about coronary inflammation, now measurable in the clinic with the FDA-authorized CaRi-Heart®. The panel will bring together foundational science and clinical imaging perspectives to assess where the field is headed. 

Faculty:
Keith Channon, MD University of Oxford (Chair)
Peter Libby, MD, Brigham and Women’s Hospital and Harvard Medical School
Brittany Weber, MD, UT Southwestern Medical Center

Click here for more information. 

This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming.